Overview

Schistosoma Mansoni in Mwanza Region, Tanzania

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the strategy for mass drug administration (MDA) which provides the greatest reductions in prevalence and intensity of Schistosoma mansoni in school-aged children after 4 years of intervention.
Phase:
N/A
Details
Lead Sponsor:
DBL -Institute for Health Research and Development
Treatments:
Praziquantel